155206-00-1 | Bimatoprost

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$9.00	$6.00
5mg	98%	in stock	$20.00	$14.00
10mg	98%	in stock	$24.00	$17.00
25mg	98%(HPLC)	in stock	$60.00	$42.00
100mg	98%(HPLC)	in stock	$177.00	$124.00
500mg	≥99%	in stock	$652.00	$457.00
1g	≥99%	in stock	$891.00	$624.00

Description

• Catalog Number: AA77208
• Chemical Name: Bimatoprost
• CAS Number: 155206-00-1
• Molecular Formula: C25H37NO4
• Molecular Weight: 415.5656
• MDL Number: MFCD03411999
• SMILES: CCNC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O

Computed Properties

• Complexity: 541
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 5
• Defined Bond Stereocenter Count: 2
• Heavy Atom Count: 30
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 12
• XLogP3: 2.8

Literature

• Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.

  The Journal of dermatology 20121001

• Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.

  Advances in therapy 20121001

• Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches.

  Journal of glaucoma 20120901

• Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy.

  Aesthetic surgery journal 20120901

• Repigmentation of hypopigmented scars using an erbium-doped 1,550-nm fractionated laser and topical bimatoprost.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20120701

• Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects.

  Japanese journal of ophthalmology 20120701

• Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.

  Journal of the American Academy of Dermatology 20120501

• Increased systemic side effects of prostaglandin analogue eye drops in patients with palatal defects.

  The British journal of oral & maxillofacial surgery 20120401

• In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120401

• Comparison of human ocular distribution of bimatoprost and latanoprost.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120401

• Lower eyelid melanoma during bimatoprost (Lumigan) therapy.

  Clinical & experimental ophthalmology 20120301

• [Massive choroidal detachment secondary to topical use of bimatoprost: Report of two cases].

  Journal francais d'ophtalmologie 20120301

• Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial.

  The British journal of ophthalmology 20120201

• The influence of central corneal thickness on response to topical prostaglandin analogue therapy.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20120201

• Bilateral upper eyelid retraction caused by topical bimatoprost therapy.

  Ophthalmic plastic and reconstructive surgery 20120101

• Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network.

  European journal of ophthalmology 20120101

• Effect of ketorolac add-on treatment on intra-ocular pressure in glaucoma patients receiving prostaglandin analogues.

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20120101

• Automated hyperemia analysis software: reliability and reproducibility in healthy subjects.

  Japanese journal of ophthalmology 20120101

• Prostaglandin-timolol fixed combinations efficacy: myth or reality?

  European journal of ophthalmology 20120101

• Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials.

  European journal of ophthalmology 20120101

• Topical bimatoprost for the treatment of eyebrow hypotrichosis.

  Journal of drugs in dermatology : JDD 20120101

• A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients.

  TheScientificWorldJournal 20120101

• Evaluation of investigator bias in industry-funded clinical trials of latanoprost.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost.

  Japanese journal of ophthalmology 20111101

• Company profits from side effects of glaucoma treatment.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20111004

• Twenty-four-hour intraocular pressure control with latanoprost-timolol-fixed combination versus bimatoprost in patients who switched from timolol.

  Journal of glaucoma 20111001

• Do prostaglandin analogs affect eyelid position and motility?

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001

• Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001

• Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001

• A case hypersensitive to bimatoprost and dexamethasone.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001

• A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs.

  Experimental eye research 20110901

• Latanoprost therapy after sunken eyes caused by travoprost or bimatoprost.

  Optometry and vision science : official publication of the American Academy of Optometry 20110901

• Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.

  The American journal of managed care 20110901

• The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes.

  Acta ophthalmologica 20110801

• Spectrofluorometry assays for oxidative stress and apoptosis, with cell viability on the same microplates: a multiparametric analysis and quality control.

  Toxicology in vitro : an international journal published in association with BIBRA 20110801

• The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.

  Cornea 20110801

• Comparison of intraocular pressure-lowering effect of every night versus every other night dosing of bimatoprost 0.03%.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110801

• Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%.

  Advances in therapy 20110801

• Bimatoprost ophthalmic solution 0.03% for eyebrow growth.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20110701

• Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution.

  Journal of drugs in dermatology : JDD 20110701

• Enhanced eyelashes: prescription and over-the-counter options.

  Aesthetic plastic surgery 20110201

• Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110201

• Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110201

• Intraocular pressure and ocular hemodynamics in patients with primary open-angle glaucoma treated with the combination of morning dosing of bimatoprost and dorzolamide hydrochloride.

  Acta ophthalmologica 20110201

• [Comparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucoma].

  [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20110201

• Serous retinal detachment induced by topical bimatoprost in a patient with Sturge-Weber syndrome.

  Eye (London, England) 20110101

• Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: a preliminary study.

  Indian journal of ophthalmology 20110101

• Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.

  Japanese journal of ophthalmology 20110101

• Persistence with prostaglandin agonist use with and without adjunctive therapy for glaucoma patients: a Canadian population-based analysis.

  The patient 20110101

• [The latest developments in glaucoma therapy using fixed combination products].

  Oftalmologia (Bucharest, Romania : 1990) 20110101

• [Fixed combination of topical prostaglandin analogue in glaucoma treatment].

  Oftalmologia (Bucharest, Romania : 1990) 20110101

• Interaction of topical alopecia and acne medications: notable stain enhancement by bimatoprost.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20101201

• Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201

• Bimatoprost versus travoprost in an Egyptian population: a hospital-based prospective, randomized study.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201

• Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues.

  Orbit (Amsterdam, Netherlands) 20101201

• Cellular basis for bimatoprost effects on human conventional outflow.

  Investigative ophthalmology & visual science 20101001

• Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.

  Clinical & experimental ophthalmology 20101001

• The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma.

  The British journal of ophthalmology 20101001

• Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.

  American journal of ophthalmology 20101001

• Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101001

• Prostaglandin efficacy and safety study undertaken by race (the PRESSURE study).

  Journal of glaucoma 20100901

• Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20100901

• Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.

  Cutaneous and ocular toxicology 20100901

• The safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.

  Journal of glaucoma 20100801

• Eyelash preservation during chemotherapy and topical prostaglandin therapy.

  Archives of internal medicine 20100726

• Successful use of bimatoprost in the treatment of alopecia of the eyelashes.

  Clinical and experimental dermatology 20100601

• Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost.

  The British journal of dermatology 20100601

• Latisse-induced periocular skin hyperpigmentation.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20100601

• Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601

• Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement.

  Journal of cosmetic dermatology 20100601

• Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes.

  Ophthalmology 20100501

• Commentary: From serendipity to pilot study and then pivotal trial: bimatoprost topical for eyelash growth.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20100501

• Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20100501

• Physicians' treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma.

  Current medical research and opinion 20100401

• Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100401

• Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension.

  American journal of ophthalmology 20100401

• [Evaluation of the effect of bimatoprost/timolol fixed combination on ocular blood flow in patients with ocular hypertension using colour Doppler imaging. Preliminary study].

  Archivos de la Sociedad Espanola de Oftalmologia 20100401

• Treatment of glaucoma in clinical practice: four-year results from a patient registry in France.

  Journal of glaucoma 20100301

• Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma.

  The British journal of ophthalmology 20100201

• Lusher lashes, but at real risk.

  Consumer reports 20100201

• Skin pigmentation after NB-UVB and three analogues of prostaglandin F(2alpha) in guinea pigs: a comparative study.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20100101

• Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study.

  The British journal of ophthalmology 20100101

• Does the fixed combination of bimatoprost/timolol really produce a better benefit/risk balance than the fixed combination of latanoprost/timolol?

  European journal of ophthalmology 20100101

• Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy.

  BMC ophthalmology 20100101

• Goldmann applanation tonometry and dynamic contour tonometry after treatment with prostaglandin analog/prostamide.

  Journal of glaucoma 20100101

• [Monotherapy with lipid structural derivatives in glaucoma].

  Oftalmologia (Bucharest, Romania : 1990) 20100101

• Topical prostaglandin analogues do not affect selective laser trabeculoplasty outcomes.

  Eye (London, England) 20091201

• Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201

• Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201

• My eyelashes have become very thin over the years, and I'm hopeless with mascara. Is it safe to use this new prescription product that's supposed to grow eyelashes?

  Mayo Clinic health letter (English ed.) 20091201

• Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells.

  Investigative ophthalmology & visual science 20091101

• Bimatoprost - a review.

  Expert opinion on pharmacotherapy 20091101

• Bilateral deepening of upper lid sulcus from topical bimatoprost therapy.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091001

• A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091001

• Comparison of the protective effects of prostaglandin analogues in the ischemia and reperfusion model of rabbit eyes.

  Experimental animals 20091001

• Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.

  Ophthalmology 20090901

• Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.

  Journal of the American Academy of Dermatology 20090901

• Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.

  American journal of ophthalmology 20090801

• Comment on Efficacy and tolerability of prostaglandin analogs.

  Journal of glaucoma 20090801

• Meta-analysis of medical intervention for normal tension glaucoma.

  Ophthalmology 20090701

• Corneal thickness and glaucoma medications.

  Ophthalmology 20090701

• Relative efficacy of prostaglandins.

  Ophthalmology 20090701

• A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma.

  The British journal of ophthalmology 20090601

• Bimatoprost 0.03% solution (latisse) for eyelash enhancement.

  The Medical letter on drugs and therapeutics 20090601

• Latisse: empirical discovery yields treatment for sparse eyelashes.

  Nursing for women's health 20090601

• Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.

  European journal of pharmacology 20090521

• Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients.

  Eye (London, England) 20090401

• Inhibition of cyclooxygenase-2 and EP1 receptor antagonism reduces human colonic longitudinal muscle contractility in vitro.

  Prostaglandins & other lipid mediators 20090401

• First-year treatment patterns among new initiators of topical prostaglandin analogs.

  Current medical research and opinion 20090401

• The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090401

• Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.

  Current medical research and opinion 20090401

• Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.

  Journal of the American Academy of Dermatology 20090401

• Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090401

• Safety and effectiveness of topical bimatoprost.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20090401

• Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.

  The British journal of ophthalmology 20090301

• Bimatoprost-induced calcium signaling in human T-cells does not involve prostanoid FP or TP receptors.

  Current eye research 20090301

• Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment.

  Journal of glaucoma 20090301

• Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090201

• The effect of prostaglandin analogs and prostamide on central corneal thickness.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090201

• Discrepancy between results and abstract conclusions in industry- vs nonindustry-funded studies comparing topical prostaglandins.

  American journal of ophthalmology 20090101

• Efficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicenter, randomized, investigator-masked, clinical study.

  European journal of ophthalmology 20090101

• Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension.

  Drugs & aging 20090101

• Incidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprost.

  European journal of ophthalmology 20090101

• A 12-week study evaluating the efficacy of bimatoprost 0.03% in patients with pseudoexfoliative and open-angle glaucoma.

  European journal of ophthalmology 20090101

• Long-term effects of prostaglandin analogues on the anterior chamber depth of patients with primary open-angle glaucoma.

  Cutaneous and ocular toxicology 20090101

• [Receptors involved in the mechanism of action of topical prostaglandines].

  Oftalmologia (Bucharest, Romania : 1990) 20090101

• Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.

  Journal of glaucoma 20090101

• [Bimatoprost therapy in glaucoma].

  Oftalmologia (Bucharest, Romania : 1990) 20090101

• Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

  Drugs & aging 20090101

• Effect of bimatoprost on intraocular pressure after cataract surgery.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20081201

• Flare-up rates with bimatoprost therapy in uveitic glaucoma.

  American journal of ophthalmology 20081201

• Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.

  Journal of glaucoma 20081201

• Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues.

  Investigative ophthalmology & visual science 20081101

• Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.

  The British journal of ophthalmology 20081001

• Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081001

• [Cost-efficacy analysis of fixed combinations of prostaglandin/prostamide for treating glaucoma].

  Archivos de la Sociedad Espanola de Oftalmologia 20081001

• Influence of topical bimatoprost on macular thickness and volume in glaucoma patients with phakic eyes.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20081001

• A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.

  American journal of ophthalmology 20080901

• Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.

  The British journal of ophthalmology 20080901

• A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801

• Comparison of the effects of latanoprost and bimatoprost on central corneal thickness.

  Journal of glaucoma 20080801

• Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

  Ophthalmology 20080701

• Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes.

  British journal of pharmacology 20080701

• [Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].

  Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20080701

• Contact dermatitis caused by latanoprost-containing eye drops with good tolerance to bimatoprost eye drops.

  Contact dermatitis 20080601

• Bimatoprost, the prodrug of a prostaglandin analogue.

  The British journal of ophthalmology 20080601

• Recurring iris pigment epithelial cyst induced by topical prostaglandin F2 alpha analogues.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20080601

• Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.

  Ophthalmology 20080501

• [Orbital fat atrophy in glaucoma patients treated with topical bimatoprost--can bimatoprost cause enophthalmos?].

  Klinische Monatsblatter fur Augenheilkunde 20080501

• Gastrointestinal adverse effects of prostaglandin analogues.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20080501

• Carotid cavernous sinus fistula presenting with pulsating exophthalmos and secondary glaucoma.

  Journal of the Indian Medical Association 20080501

• Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%.

  Current medical research and opinion 20080401

• A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.

  Current medical research and opinion 20080401

• In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.

  Current eye research 20080401

• Meta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressure.

  Clinical therapeutics 20080401

• A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension.

  Advances in therapy 20080301

• Synthetic FP-prostaglandin-induced contraction of rat uterus smooth muscle in vitro.

  Prostaglandins, leukotrienes, and essential fatty acids 20080301

• The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.

  Eye (London, England) 20080201

• Prostamides (prostaglandin-ethanolamides) and their pharmacology.

  British journal of pharmacology 20080201

• Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.

  American journal of ophthalmology 20080201

• Efficacy and safety of bimatoprost/timolol fixed combination in the treatment of glaucoma or ocular hypertension.

  Expert opinion on pharmacotherapy 20080101

• A comparative study of bimatoprost and travoprost: effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients.

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20080101

• The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.

  Journal of glaucoma 20080101

• Physician attitudes regarding prostaglandin treatment for glaucoma in the United States and Europe.

  European journal of ophthalmology 20080101

• Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.

  Journal of glaucoma 20080101

• Comparison of ocular surface side effects of topical travoprost and bimatoprost.

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20080101

• Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use study.

  BMC ophthalmology 20080101

• Periorbital changes associated with topical bimatoprost.

  Ophthalmic plastic and reconstructive surgery 20080101

• [Considerations about administration angle of prostaglandin analogs].

  Arquivos brasileiros de oftalmologia 20080101

• [Fixed combinations of glaucoma medications].

  Oftalmologia (Bucharest, Romania : 1990) 20080101

• Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.

  Ophthalmology 20071201

• Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.

  Acta ophthalmologica Scandinavica 20071201

• Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201

• The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.

  Current eye research 20071201

• A gap analysis approach to assess patient persistence with glaucoma medication.

  American journal of ophthalmology 20071001

• Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071001

• [Malar and ciliary hypertrichosis induced by bimatoprost].

  Annales de dermatologie et de venereologie 20071001

• Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.

  Ophthalmology 20070901

• Bimatoprost, prostamide activity, and conventional drainage.

  Investigative ophthalmology & visual science 20070901

• Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle.

  Investigative ophthalmology & visual science 20070801

• Comparative evaluation of bimatoprost monotherapy in primary chronic angle closure and primary open angle glaucoma eyes: a three-year study.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070801

• Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.

  The British journal of ophthalmology 20070601

• Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract.

  The British journal of ophthalmology 20070501

• Effect of bimatoprost on intraocular pressure after phacoemulsification in eyes with exfoliation syndrome.

  Acta ophthalmologica Scandinavica 20070501

• A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma.

  Current medical research and opinion 20070501

• 24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension.

  Eye (London, England) 20070401

• Accounting for restart rates in evaluating persistence with ocular hypotensives.

  Ophthalmology 20070401

• A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.

  Current medical research and opinion 20070301

• A 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%: hypotensive efficacy, macular thickness and flare in ocular-hypertensive and glaucoma patients.

  Eye (London, England) 20070201

• Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.

  Acta ophthalmologica Scandinavica 20070201

• Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.

  The British journal of ophthalmology 20070101

• A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension.

  European journal of ophthalmology 20070101

• A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension.

  European journal of ophthalmology 20070101

• Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.

  BMC ophthalmology 20070101

• Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis.

  Clinical drug investigation 20070101

• The effect of ocular hypotensive agents on macula.

  Annals of ophthalmology (Skokie, Ill.) 20070101

• Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study.

  Arquivos brasileiros de oftalmologia 20070101

• Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.

  American journal of ophthalmology 20061201

• Efficiency of instillation methods for prostaglandin medications.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061201

• Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

  The British journal of ophthalmology 20061101

• Clinical course of bimatoprost-induced periocular skin changes in Caucasians.

  Ophthalmology 20061101

• Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

  The British journal of ophthalmology 20061101

• Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.

  Clinical & experimental ophthalmology 20061101

• Comparing bimatoprost and travoprost in black Americans.

  Current medical research and opinion 20061101

• Comments on The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries.

  Current medical research and opinion 20061001

• Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.

  American journal of ophthalmology 20060801

• [Cystoid macular edema in a pseudophakic patient after several glaucoma procedures. Is local therapy with bimatoprost the reason?].

  Klinische Monatsblatter fur Augenheilkunde 20060601

• Effects of bimatoprost 0.03% on ocular hemodynamics in normal tension glaucoma.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20060601

• The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries.

  Current medical research and opinion 20060501

• Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.

  Current medical research and opinion 20060501

• Decreased high-density lipoprotein serum levels associated with topical bimatoprost therapy.

  Optometry (St. Louis, Mo.) 20060401

• Recurrence of bilateral herpes simplex virus keratitis following bimatoprost use.

  Indian journal of ophthalmology 20060301

• Prostaglandin F2alpha formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost.

  Biochemistry 20060221

• Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.

  Ophthalmology 20060201

• The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20060201

• Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.

  American journal of ophthalmology 20060101

• Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes.

  Veterinary ophthalmology 20060101

• Estimated comparative costs of achieving a 20% reduction in intraocular pressure with bimatoprost or latanoprost in patients with glaucoma or ocular hypertension.

  Drugs & aging 20060101

• Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.

  PharmacoEconomics 20060101

• Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension.

  PharmacoEconomics 20060101

• Prospective comparative switch study from timolol 0.5% and latanoprost 0.005% to bimatoprost 0.03%.

  Advances in therapy 20060101

• Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.

  PharmacoEconomics 20060101

• A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma.

  Advances in therapy 20060101

• Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.

  Ophthalmology 20051201

• Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.

  Investigative ophthalmology & visual science 20051201

• In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.

  Investigative ophthalmology & visual science 20051201

• The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.

  Investigative ophthalmology & visual science 20051101

• Bimatoprost-induced periocular skin hyperpigmentation: histopathological study.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20051101

• Periocular cutaneous pigmentary changes associated with bimatoprost use.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20051101

• A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy.

  Current medical research and opinion 20051101

• Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.

  Current medical research and opinion 20051101

• The cost-effectiveness of bimatoprost 0.03% in the treatment of glaucoma in adult patients--a European perspective.

  International journal of clinical practice 20050901

• Efficacy and safety of bimatoprost for the treatment of open-angle glaucoma and ocular hypertension: a three-month, open-label study in community-based practices in Thailand.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20050901

• Bimatoprost.

  Ophthalmology 20050801

• Choroidal detachment after topical prostaglandin analogs: case report.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20050801

• In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.

  Investigative ophthalmology & visual science 20050701

• Additivity of pilocarpine to bimatoprost in ocular hypertension and early glaucoma.

  Journal of glaucoma 20050601

• Clinical pharmacology of bimatoprost.

  Expert opinion on drug metabolism & toxicology 20050601

• Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial.

  The British journal of ophthalmology 20050501

• Corneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedrops.

  American journal of ophthalmology 20050401

• [Hyperpigmentosis and hypertrichosis of the eyelids after use of bimatoprost eye drops].

  Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20050401

• [Bimatoprost in the treatment of ocular hypertension and chronic glaucoma].

  Journal francais d'ophtalmologie 20050301

• Studies using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have different activity profiles.

  British journal of pharmacology 20050201

• Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.

  Ophthalmology 20050201

• Bimatoprost versus timolol and dorzolamide.

  Ophthalmology 20050201

• Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20050201

• Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells.

  Experimental eye research 20050101

• [The more favourable cost/effectiveness ratio of latanoprost vs bimatoprost and travoprost when using normally for treatment of glaucoma].

  Archivos de la Sociedad Espanola de Oftalmologia 20050101

• Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428].

  BMC ophthalmology 20050101

• Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combination.

  European journal of ophthalmology 20050101

• Efficacy and safety of bimatoprost in patients with uncontrolled glaucoma as alternative to filtration surgery.

  European journal of ophthalmology 20050101

• The effects of bimatoprost and unoprostone isopropyl on the intraocular pressure of normal cats.

  Veterinary ophthalmology 20050101

• Bimatoprost: mechanism of ocular surface hyperemia associated with topical therapy.

  Cardiovascular drug reviews 20050101

• Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery.

  Ophthalmology 20041201

• Stopping prostaglandin analogues in uneventful cataract surgery.

  Journal of cataract and refractive surgery 20041201

• Hypertrichosis of the eyelashes caused by bimatoprost.

  Journal of the American Academy of Dermatology 20041101

• Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20041001

• A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20041001

• Short-term effects of bimatoprost in glaucoma patients from an outpatient clinic.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20041001

• A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20040901

• Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20040901

• Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.

  Ophthalmology 20040901

• Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20040901

• Conjunctival hyperemia associated with bimatoprost use: a histopathologic study.

  American journal of ophthalmology 20040801

• Deepening of lid sulcus from topical bimatoprost therapy.

  Optometry and vision science : official publication of the American Academy of Optometry 20040801

• The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20040801

• [Ocular hemodynamics in normal tension glaucoma: effect of bimatoprost].

  Klinische Monatsblatter fur Augenheilkunde 20040701

• Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription.

  British journal of pharmacology 20040601

• Topical prostaglandin F(2alpha) analog induced poliosis.

  American journal of ophthalmology 20040501

• Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprost.

  American journal of ophthalmology 20040501

• Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS.

  Archives of biochemistry and biophysics 20040415

• Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.

  American journal of ophthalmology 20040401

• Increased periocular pigmentation with ocular hypotensive lipid use in African Americans.

  American journal of ophthalmology 20040401

• Efficacy of bimatoprost 0.03 percent in untreated glaucoma and ocular hypertension patients: results from a large community-based clinical trial.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20040401

• [Recent changes in glaucoma management].

  Nippon Ganka Gakkai zasshi 20040401

• Bimatoprost: establishing its role in glaucoma management.

  Survey of ophthalmology 20040301

• Update on the mechanism of action of bimatoprost: a review and discussion of new evidence.

  Survey of ophthalmology 20040301

• Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

  Survey of ophthalmology 20040301

• A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.

  Survey of ophthalmology 20040301

• 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

  Survey of ophthalmology 20040301

• A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension.

  Survey of ophthalmology 20040301

• Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.

  Survey of ophthalmology 20040301

• A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study.

  American journal of ophthalmology 20040201

• Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

  American journal of ophthalmology 20040101

• Contact dermatitis from topical bimatoprost.

  Contact dermatitis 20040101

• Bimatoprost: a novel antiglaucoma agent.

  Cardiovascular drug reviews 20040101

• Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study.

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20040101

• [Theoretical and clinical aspects of the use of prostaglandins in glaucoma therapy].

  Klinika oczna 20040101

• A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension.

  Survey of ophthalmology 20040101

• Unilateral trichomegaly induced by bimatoprost ophthalmic solution.

  Journal of drugs in dermatology : JDD 20040101

• Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials.

  Advances in therapy 20040101

• The efficacy of bimatoprost 0.03% monotherapy in patients previously using topical beta-blocker monotherapy for the treatment of glaucoma or ocular hypertension.

  Advances in therapy 20040101

• A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.

  Ophthalmology 20031201

• Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects.

  Journal of glaucoma 20031201

• Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20031201

• Bilateral nongranulomatous anterior uveitis associated with bimatoprost.

  Journal of cataract and refractive surgery 20031101

• Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.

  Investigative ophthalmology & visual science 20031001

• The prostaglandin wars.

  American journal of ophthalmology 20031001

• Latanoprost versus bimatoprost.

  Ophthalmology 20030901

• Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

  American journal of ophthalmology 20030801

• Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression.

  The Journal of biological chemistry 20030718

• Randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

  American journal of ophthalmology 20030701

• A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

  American journal of ophthalmology 20030601

• Ocular hypotensive efficacy of bimatoprost when used as a replacement for latanoprost in the treatment of glaucoma and ocular hypertension.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030601

• Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).

  The Journal of pharmacology and experimental therapeutics 20030501

• A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

  American journal of ophthalmology 20030501

• Increased periocular pigmentation with ocular hypotensive lipid use in African Americans.

  American journal of ophthalmology 20030501

• Update on prostaglandin analogs.

  Current opinion in ophthalmology 20030401

• The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2alpha by human and rabbit ocular tissue.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030401

• Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030401

• Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.

  Clinical therapeutics 20030401

• Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.

  American journal of ophthalmology 20030301

• Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.

  Ophthalmology 20030301

• Vasoactive properties of bimatoprost in isolated porcine ciliary arteries.

  Klinische Monatsblatter fur Augenheilkunde 20030301

• Granulomatous anterior uveitis associated with bimatoprost: a case report.

  Ocular immunology and inflammation 20030301

• Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.

  Investigative ophthalmology & visual science 20030201

• New topical drugs for open-angle glaucoma.

  Drug and therapeutics bulletin 20030201

• Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitro.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030201

• A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.

  The British journal of ophthalmology 20030101

• Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.

  The Journal of pharmacology and experimental therapeutics 20030101

• A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

  American journal of ophthalmology 20030101

• Bimatoprost (Lumigan((R))) is an agonist at the cloned human ocular FP prostaglandin receptor: real-time FLIPR-based intracellular Ca(2+) mobilization studies.

  Prostaglandins, leukotrienes, and essential fatty acids 20030101

• Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension.

  Advances in therapy 20030101

• Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension.

  Advances in therapy 20030101

• Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension.

  Advances in therapy 20030101

• An update on bimatoprost in glaucoma therapy.

  Expert opinion on pharmacotherapy 20021201

• Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous Beagle.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20021201

• One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20021001

• Reappraising first-line treatment in glaucoma management.

  Hospital medicine (London, England : 1998) 20020901

• The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist.

  Survey of ophthalmology 20020801

• Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.

  Survey of ophthalmology 20020801

• Medical treatment of normal tension glaucoma.

  Survey of ophthalmology 20020801

• Mechanism and clinical significance of prostaglandin-induced iris pigmentation.

  Survey of ophthalmology 20020801

• Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020801

• An accurate comparison of bimatoprost's efficacy and adverse effects.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20020701

• Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprost.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20020601

• Bimatoprost vs. timolol.

  Ophthalmology 20020401

• Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma.

  American journal of ophthalmology 20020301

• Cystoid macular edema associated with ocular hypotensive lipids.

  American journal of ophthalmology 20020301

• Prostaglandin analog treatment of glaucoma and ocular hypertension.

  The Annals of pharmacotherapy 20020301

• Drug and device approval highlights from 2001.

  The Nurse practitioner 20020201

• Pharmacological considerations in the treatment of glaucoma.

  Managed care (Langhorne, Pa.) 20020101

• Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

  Drugs & aging 20020101

• New drugs 2002, part 1.

  Nursing 20020101

• Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost.

  Advances in therapy 20020101

• Bimatoprost and its free acid are prostaglandin FP receptor agonists.

  European journal of pharmacology 20011207

• Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20010701

• Two new ophthalmic solutions enter glaucoma market.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010615

• Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.

  Ophthalmology 20010601

• The pharmacology of bimatoprost (Lumigan).

  Survey of ophthalmology 20010501

• Mechanism of action of bimatoprost (Lumigan).

  Survey of ophthalmology 20010501

• Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.

  Survey of ophthalmology 20010501

• Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.

  Survey of ophthalmology 20010501

• Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management.

  Expert opinion on investigational drugs 20010401

• Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics.

  American journal of ophthalmology 20010101

• New drugs for glaucoma.

  FDA consumer 20010101

• Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension.

  Advances in therapy 20010101